These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 24919928
41. HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. Shahbazi M, Ebadi H, Fathi D, Roshandel D, Mohamadhosseni M, Tahmasebi A, Shahbazi S, Zamani M, Rashidbaghan A. Mult Scler; 2010 Oct; 16(10):1173-7. PubMed ID: 20685768 [Abstract] [Full Text] [Related]
42. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk. Nolan D, Castley A, Tschochner M, James I, Qiu W, Sayer D, Christiansen FT, Witt C, Mastaglia F, Carroll W, Kermode A. Neurology; 2012 Aug 07; 79(6):538-46. PubMed ID: 22786591 [Abstract] [Full Text] [Related]
43. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients. Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. Int J Immunogenet; 2008 Apr 07; 35(2):133-40. PubMed ID: 18279373 [Abstract] [Full Text] [Related]
44. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer. Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Urol Oncol; 2013 Oct 07; 31(7):1132-40. PubMed ID: 22317880 [Abstract] [Full Text] [Related]
45. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases. Lobnig BM, Chantelau E, Vidgrén G, Van Landeghem AA, Kinnunen L, Tuomilehto-Wolf E. Diabetes Metab; 2002 Jun 07; 28(3):217-21. PubMed ID: 12149602 [Abstract] [Full Text] [Related]
46. Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study. Apperson ML, Tian Y, Stamova B, Ander BP, Jickling GC, Agius MA, Sharp FR. J Neuroimmunol; 2013 Apr 15; 257(1-2):90-6. PubMed ID: 23477965 [Abstract] [Full Text] [Related]
49. IL2RA gene polymorphism rs2104286 A>G seen in multiple sclerosis is associated with intermediate uveitis: possible parallel pathways? Lindner E, Weger M, Steinwender G, Griesbacher A, Posch U, Ulrich S, Wegscheider B, Ardjomand N, El-Shabrawi Y. Invest Ophthalmol Vis Sci; 2011 Oct 21; 52(11):8295-9. PubMed ID: 21911588 [Abstract] [Full Text] [Related]
50. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, Palmgren J, Hillert J. PLoS One; 2007 Jul 25; 2(7):e664. PubMed ID: 17653284 [Abstract] [Full Text] [Related]
51. TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients. Akcali A, Pehlivan S, Pehlivan M, Sever T, Akgul P, Neyal M. Int J Immunogenet; 2010 Apr 25; 37(2):91-5. PubMed ID: 20082645 [Abstract] [Full Text] [Related]
52. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study. Liguori M, Healy BC, Glanz BI, Khoury SJ, Moscufo N, Weiner HL, De Jager PL, Guttmann CR. Genes Immun; 2011 Apr 25; 12(3):183-90. PubMed ID: 21179117 [Abstract] [Full Text] [Related]
54. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium. Chao MJ, Barnardo MC, Lui GZ, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Sadovnick AD, Ebers GC. Hum Mol Genet; 2007 Aug 15; 16(16):1951-8. PubMed ID: 17584771 [Abstract] [Full Text] [Related]
55. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. Kaushansky N, Altmann DM, Ascough S, David CS, Lassmann H, Ben-Nun A. J Immunol; 2009 Sep 01; 183(5):3531-41. PubMed ID: 19648275 [Abstract] [Full Text] [Related]
56. Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - A pilot study. Yamout B, Karaky NM, Mahfouz RAR, Jaber F, Estaitieh N, Shamaa D, Abbas F, Hoteit R, Daher RT. J Neuroimmunol; 2016 Apr 15; 293():59-64. PubMed ID: 27049563 [Abstract] [Full Text] [Related]
57. Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico. González-Enríquez GV, Torres-Mendoza BM, Márquez-Pedroza J, Macías-Islas MA, Ortiz GG, Cruz-Ramos JA. Immunogenetics; 2018 Aug 15; 70(8):547-551. PubMed ID: 29397401 [Abstract] [Full Text] [Related]
58. Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients. Shawkatová I, Javor J, Párnická Z, Bucová M, Čopíková-Cudráková D, Michalík J, Gmitterová K, Čierny D, Buc M, Ďurmanová V. Folia Microbiol (Praha); 2017 Jul 15; 62(4):287-293. PubMed ID: 28130760 [Abstract] [Full Text] [Related]
59. The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis. Ben Fredj N, Sakly K, Bortolotti D, Aissi M, Frih-Ayed M, Rotola A, Caselli E, Cura F, Sakly N, Aouni M, Di Luca D, Rizzo R. Immunol Lett; 2016 Dec 15; 180():24-30. PubMed ID: 27771469 [Abstract] [Full Text] [Related]
60. Three allele combinations associated with multiple sclerosis. Favorova OO, Favorov AV, Boiko AN, Andreewski TV, Sudomoina MA, Alekseenkov AD, Kulakova OG, Gusev EI, Parmigiani G, Ochs MF. BMC Med Genet; 2006 Jul 26; 7():63. PubMed ID: 16872485 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]